Insightec highlights MRgFUS study for Parkinson's disease

Insightec highlights a study of MR-guided focused ultrasound (MRgFUS) for Parkinson's disease; the press release does not provide specific efficacy or safety data.

• Insightec, the manufacturer of the Exablate Neuro MRgFUS system, is promoting a clinical study of its technology for treating Parkinson's disease.
• The announcement lacks details on study design, patient population, or primary endpoints, making it impossible to assess the evidence.
• Information comes from a trade-level press release, which may be promotional; independent validation is not provided.

RadPigeon summaries are original and for information only. They are not clinical advice.